Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer

This is a randomized controlled study assessing outcome of low (no or limited) versus high (limited or extended) extent of lymph node dissection in addition to radical prostatectomy in patients with operable localized or locally advanced prostate cancer.

Trial Details

NCT ID
NCT07308990
Phase
NA
Sponsor
N.N. Alexandrov National Cancer Centre
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Radical prostatectomy with extended / limited lymph node dissection
  • Radical prostatectomy with limited / no lymph node dissection
Locations (sample)
  • Lyasny, Minsk Oblast, Belarus|54.0072,27.6963

Key Eligibility Criteria

  • Age over 18 years.
  • Histologically confirmed localized or locally advanced prostate cancer (adenocarcinoma without a neuroendocrine component).
  • No evidence of metastatic spread of the tumor
  • Local resectability of the tumor according to digital rectal examination and/or CT and/or MRI of the pelvis

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →